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apo-tetramer is slightly less prone to unfolding and aggre-
gation than the apo-dimer. The possible implications of the 
data for the intracellular stability and regulation of hOAT 
are discussed.
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AUC  Analytical ultracentrifugation
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1 Introduction
Ornithine δ-aminotransferase (OAT) (EC 2.6.1.13), or 
ornithine: 2-oxo-glutarate aminotransferase, is a pyridoxal 
5′phosphate (PLP)-dependent enzyme that catalyzes the 
δ-transamination of l-ornithine (l-Orn) and α-ketoglutarate 
(α-KG) to glutamic-γ-semialdehyde (GSA) and l-gluta-
mate in the mitochondrial matrix. GSA then spontaneously 
cyclizes forming pirroline-5-carboxylate (P5C), a proline 
precursor. Mammalian OAT is mostly present in liver, kid-
ney and eyes, even if the enzyme is expressed in almost all 
tissues [1–3]. The proposed physiological role of OAT is 
to control the intra-mitochondrial concentration of l-Orn. 
Recently, a role for OAT in mitotic cell division has been 
Abstract Human ornithine δ-aminotransferase (hOAT) 
(EC 2.6.1.13) is a mitochondrial pyridoxal 5′-phosphate 
(PLP)-dependent aminotransferase whose deficit is associ-
ated with gyrate atrophy, a rare autosomal recessive disor-
der causing progressive blindness and chorioretinal degen-
eration. Here, both the apo- and holo-form of recombinant 
hOAT were characterized by means of spectroscopic, 
kinetic, chromatographic and computational techniques. 
The results indicate that apo and holo-hOAT (a) show a 
similar tertiary structure, even if apo displays a more pro-
nounced exposure of hydrophobic patches, (b) exhibit a 
tetrameric structure with a tetramer-dimer equilibrium 
dissociation constant about fivefold higher for the apo-
form with respect to the holoform, and (c) have apparent 
 Tm values of 46 and 67 °C, respectively. Moreover, unlike 
holo-hOAT, apo-hOAT is prone to unfolding and aggre-
gation under physiological conditions. We also identified 
Arg217 as an important hot-spot at the dimer–dimer inter-
face of hOAT and demonstrated that the artificial dimeric 
variant R217A exhibits spectroscopic properties,  Tm values 
and catalytic features similar to those of the tetrameric spe-
cies. This finding indicates that the catalytic unit of hOAT 
is the dimer. However, under physiological conditions the 
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proposed, suggesting that the protein could represent a 
target for chemotherapeutic drug development [4]. The 
enzyme is also of medical interest because the OAT deficit 
causes gyrate atrophy, a rare autosomal recessive hereditary 
disorder leading to progressive blindness and chorioretinal 
degeneration characterized by the appearance of sharply 
demarcated circular areas of chorioretinal atrophy [5, 6].
OAT is synthesized as a 49 kDa precursor in the cytosol 
and it is then imported into mitochondria where it reaches 
the functional conformation upon removal of an N-terminal 
mitochondrial targeting sequence (residues 1–25) produc-
ing a ~45 kDa mature protein [7]. Unlike OATs from plant 
sources that were found monomeric [8, 9] or from some 
bacterial [10] or protozoa [11, 12] that were found homodi-
meric, mammalian OATs show a higher level of subunits 
assembly but their quaternary structure is controversial. 
In fact ultracentrifugation and SEC studies on the OAT 
purified from rat and human liver [13–15] indicated that 
the enzyme has a tetrameric assembly. Accordingly, high 
resolution electron microscopy studies on OAT purified 
from pig kidney indicated that the holoenzyme is a homo-
tetramer [16]. Moreover, Sanada et  al. have reported that 
the apo-OAT exists in dimeric form [14] raising a question 
about the possible role of the PLP in the OAT oligomeri-
zation. Nevertheless, analytical ultracentrifugation studies 
on crude extract of rat liver have suggested that OAT pre-
sents a molecular weight dependent on the enzyme concen-
tration assuming a two-step aggregation of the monomer 
forming at first trimers (130–140 kDa) and then hexamers 
(280  kDa) [17]. Crystallographic studies on purified rat 
liver OAT [18] and, more recently, on human recombi-
nant OAT (hOAT) both ligand-free [19] and in complex 
with different substrate analogues [20, 21], indicated that 
the human enzyme could also assume an hexameric assem-
bly composed by three homodimers hold together mainly 
by electrostatic interactions. Moreover, on the basis of the 
hOAT crystal structure, the dimeric unit of the enzyme 
belongs to the fold type I class of PLP-enzymes and it was 
proposed that the dimer could represent the functional unit 
of the enzyme [19]. However, a comprehensive investiga-
tion of the biochemical properties of the hOAT as well as of 
the coenzyme role on hOAT oligomerization and stability 
is still lacking. Here, we demonstrated that although both 
holo- and apo-hOAT share a similar tertiary structure and 
a tetrameric structure, the apo, as compared with the holo, 
exhibits (a) a more pronounced exposure of hydrophobic 
surface, (b) a fivefold higher tetramer–dimer equilibrium 
dissociation constant  (KD(tet−dim)) value, (c) a 21 °C lower 
 Tm value, and (d) an higher propensity to aggregation under 
physiological conditions. Additionally, the identification of 
Arg217 as a hot spot of dimer–dimer interface prompted us 
to construct, clone, and purify the R217A mutant. Its bio-
chemical characterization revealed that the mutant form 
has a dimeric structure with spectroscopic and catalytic 
features as well as apparent  Tm values comparable with 
the corresponding ones of tetrameric hOAT, thus strongly 
suggesting that in hOAT the dimer is the functional unit. 
Nevertheless, we found that the apo-tetrameric form is 
slightly less prone to unfolding and aggregation than the 
apo-dimeric one. Based on these results, the possible role 
of PLP in the intracellular stability and oligomeric state of 
hOAT is discussed.
2  Materials and Methods
2.1  Materials
PLP, l-Orn, α-KG, 2-aminobenzaldehyde, dimethyl sul-
phoxide (DMSO), isopropyl-β-d-thiogalactoside (IPTG), 
phenylhydrazine hydrochloride and phenylmethylsulfonyl 
fluoride (PMSF) were purchased from Sigma. 1,8-Ani-
lino-naphthalene sulfonic acid (ANS) was purchased from 
Molecular Probes. All other chemicals were of the highest 
purity available. The pYES2.1::hOAT expression plasmid 
coding for the complete cDNA of hOAT [22] was kindly 
provided by Prof. Leonardo Salviati of the University of 
Padova (Italy).
2.2  Cloning and Site-Directed Mutagenesis
The 26–439 coding sequence of hOAT was equipped with 
5′ NdeI and 3′ HindIII restriction sites by extension PCR 
using the pYES2.1::hOAT vector as template and the 5′ 
CGG CTC ATA TGA CAT CTG TTG CAA CTA AAA AAA 
CAG 3′ forward primer and the 5′ CCG ACA AGC TTT 
CAG AAA GAC AAG ATG GTC TTG 3′ reverse primer. 
To construct the pOAT expression plasmid, the amplified 
sequence was cloned in a pET43a expression vector by 
means of the above mentioned restriction sites. The pOAT-
R217A expression vector was constructed using the Quick 
change II kit (Agilent Technologies), the pOAT vector as 
template, and the oligonucleotide 5′ CTG CCC GCA CTG 
GAG GCT GCT CTT CAG GAT CCA AAT G 3′ and its com-
plement. The mutation was confirmed by DNA sequence 
analysis of the whole coding region.
2.3  Expression and Purification
Escherichia coli BL21(DE3)pLysS cells transformed with 
the pOAT or pOAT-R217A mutant expression plasmid 
were grown in 4.5  L of Luria broth at 37 °C to a turbid-
ity of 0.6–0.8 at 600  nm. Expression was induced with 
0.5 mM IPTG for 15 h at 30 °C. Cells were harvested and 
resuspended in 20  mM sodium phosphate buffer, pH 7.6 
(buffer A) containing a protease inhibitor cocktail (Roche), 
Oligomeric State and Thermal Stability of Apo- and Holo- Human Ornithine δ-Aminotransferase 
1 3
0.1 mM EDTA, 50 μM PLP and 0.5 mM PMSF. Lysozyme 
was added to a concentration of 0.2  mg/mL and the cul-
ture was incubated for 20 min at room temperature. After a 
freeze–thaw, leupeptin (0.5 μg/mL) and pepstatin (0.7 μg/
mL) were added and the suspension was centrifuged at 
30,000g for 30  min at 4 °C. The supernatant was recov-
ered, adjusted to pH 7.6 and loaded on a DEAE Sepha-
rose 26/20 equilibrated with buffer A. A linear gradient 
(240 mL) from 20 to 150 mM sodium phosphate buffer, pH 
7.6, was then applied. Under these conditions, OAT elutes 
from the column between 110 and 140 mM sodium phos-
phate. Active fractions were pooled and reconstituted with 
100 μM PLP. The solution was then concentrated using an 
Amicon Ultra 15 unit (Millipore) and applied to a Super-
dex 200 XK 26/60 column (GE Healthcare) equilibrated 
in 50 mM Hepes, pH 7.4, NaCl 200 mM. The eluted pro-
tein was concentrated using an Amicon Ultra 15 unit and 
stored at −20 °C. This method, yielding about 35  mg of 
pure protein per litre of bacterial culture, is summarized 
in Table  1. The PLP content of the enzyme was deter-
mined by releasing the coenzyme in 0.1 M NaOH and by 
using εM = 6600 M−1 cm−1 at 388 nm. The apparent molar 
absorption coefficient at 280 nm of OAT dimer was deter-
mined following the method of Pace [23] and found to be 
124,767 M−1 cm−1. In this work the enzymatic molar con-
centration is expressed as dimer equivalents.
2.4  Enzyme Activity Assay
The OAT enzymatic activity was determined by a spec-
trophotometric assay measuring the dihydroquinazolium 
derivative of P5C after incubation with 2-aminobenzalde-
hyde. The purified protein (0.06–1 μM) was incubated with 
saturating concentration of l-Orn (100  mM) and α-KG 
(50 mM) in 50 mM Hepes, pH 8.0, 150 mM NaCl at 25 °C 
in the presence of 100 μM PLP. Reaction was stopped by 
addition of trichloroacetic acid  10% (v/v). A fresh solu-
tion of o-aminobenzaldehyde was prepared in 0.7 M HCl, 
30% DMSO, and added to the samples at 15 mM final con-
centration. Samples were incubated at 25 °C for 40  min 
to allow the development of the color. After centrifuga-
tion (12,000g for 2 min), the absorbance at 440 nm of the 
recovered supernatant was measured and a molar extinction 
coefficient of 2.71 × 103  M−1  cm−1 was used to calculate 
the amount of P5C formed.
2.5  Apoenzyme Preparation
The apo-form of wild-type OAT and of the R217A vari-
ant were obtained by incubating the enzyme at 5 μM con-
centration with 80  mM phenylhydrazine hydrochloride in 
0.5 M potassium phosphate buffer pH 6.9 for 1 h at 25 °C in 
the dark. The solution was then loaded on a Hiprep 26/10 
desalting column (Amersham) equilibrated with 50  mM 
Hepes, pH 7.4, 0.5  M NaCl. The eluted apoenzyme was 
concentrated by means of an Amicon ultra 4 unit (Milli-
pore) and stored at −20 °C.
2.6  Spectroscopic Measurements
Absorption measurements were performed by a Jasco 
V-550 spectrophotometer at a protein concentration of 
6 μM. CD measurements were made by a Jasco J-710 spec-
tropolarimeter at a protein concentration of 6 μM. The ANS 
emission spectra were recorded upon excitation at 365 nm 
of a 6  μM enzyme sample previously incubated with 
150 μM ANS for 1 h at 25 °C in the dark. The ANS binding 
of the holo-forms was registered in the presence of 20 µM 
PLP. Measurements were performed by a FP Jasco spec-
trofluorimeter setting 5  nm excitation and emission band-
widths. Spectroscopic analyses under physiological condi-
tions were performed in phosphate-buffered saline (PBS) 
pH 8.0. All other spectroscopic measurements were carried 
out in 50  mM Hepes, pH 7.4, 0.5  M NaCl. The equilib-
rium dissociation constant for PLP  (KD(PLP)) of wild-type 
and the mutant enzyme was determined by measuring the 
quenching of the intrinsic fluorescence of the apoenzyme at 
90 nM upon incubation with PLP at a concentration range 
of 0.01–10  μM for 2  h at 25 °C. The  KD(PLP) value was 
obtained using the following equation:
Table 1  Purification procedure of hOAT from 1 L of bacterial culture
Protein (mg) Total activity (units) Specific activity (units/mg) Yield (%) Purification (fold)
Cleared lysate 830 1950 2.3 100 –
DEAE sepharose 72 1220 17 62 7.4
























 R. Montioli et al.
1 3
where  [E]t and  [PLP]t represent the total concentration of 
OAT and PLP, respectively, Y refers to the changes of the 
emission fluorescence signal at 338 nm at a PLP concentra-
tion  [PLP]t, and  Ymax refers to the maximum change of the 
fluorescence intensity when all enzyme molecules are com-
plexed with coenzyme.
2.7  In Silico Analysis
The OAT tetramer was constructed starting from the 
available pdb file of hOAT (1OAT.pdb). The structures 
of the complete dimer were used as template to add the 
missing chain by means of the structural alignment tool 
of the MOE software (Chemical Computing Group) [24]. 
The protonation state was applied by PROTONATE 3D 
tool of MOE software setting 150  mM ionic strength 
and pH 8.0. The structure was refined using the energy 
minimization tool of the MOE software applying the 
AMBER99 force field.
2.8  Dynamic Light Scattering (DLS) Analysis
DLS measurements were made on a Zetasizer Nano S 
device from Malvern Instruments. To analyze the par-
ticles diameter, the enzymatic species were diluted in 
50  mM Hepes, pH 7.4, 0.5  M NaCl at 25 °C. PLP was 
added to the holoenzyme solutions to a final concentra-
tion of 50 μM. The buffer was filtered using Anotop 10 
filters (Whatman) immediately before use to eliminate 
any impurities.
2.9  Analytical Ultracentrifugation (AUC)
Sedimentation velocity experiments were performed on a 
Beckman Coulter Proteomelab XLI analytical ultracentri-
fuge equipped with absorbance optics. The experiments 
were conducted at 25,000 rpm at 20 °C at a protein con-
centration of 6  µM in the buffers 50  mM Hepes 0.5  M 
NaCl pH 7.4. Radial absorbance scans were collected at 
280  nm at a spacing of 0.003  cm with three average in 
a continous scan mode. Sedimentation coefficients were 
determined using the program Sedfit (provided by Dr P. 
Schuck, National Institutes of Health) and were reduced 
to water  (S20,W) using standard procedures.
2.10  Size Exclusion Chromatography (SEC) Analysis
SEC experiments were performed with an AKTA FPLC 
system (GE Healthcare) equipped with an UV–visible 
detector at 280  nm using a custom packed Sephacryl 
S-300 10/600 column. The calibration curve of the 
column was obtained by means of gel filtration standard 
markers (Bio-Rad) and resulted in:
where MW is the molecular weight and Ve is the elution 
volume of the protein. Apo and holo-hOAT samples were 
dissolved in running buffer at different concentrations 
(ranging from 0.3 to 75 μM) and incubated for 30 min at 
25 °C. Samples were then loaded on the column equili-
brated in 50 mM Hepes, pH 7.4, 0.5 M NaCl. The injection 
volume was 0.1 mL and the flow rate was 0.4 mL/min. The 
elution profiles were analysed using the software Unicorn 
5.0 (GE Healthcare). The percentage of tetramer (%T) of 
each sample was calculated from the elution curves follow-
ing the method of Manning et al. [25]. Assuming that the 
elution volume (Ve) varies as a function of the molecular 
weight (MW) it follows that:
where D is the molecular weight of the dimer, Vd and Vt 
are the elution volumes of the dimeric and tetrameric spe-
cies respectively. At a given enzyme concentration the 
effective MW is given by:
where D is the MW of the dimeric species and %T is the 
percentage of the tetramer present. Combining Eqs. 2 and 
3 gives:
The dimer–tetramer equilibrium dissociation con-
stant  (KD(dim−tet)) was calculated following the method 
of Manning et al. [25]. Assuming that  [Ttot] is the maxi-
mal amount of OAT tetramer and [T] and [D] denote the 
concentrations of tetrameric and dimeric OAT respec-
tively, the plot of log(%T/0.04 (100 − %T)2) vs. log  [Ttot], 
gives a straight line with a slope 1. When (%T/0.04 
(100 − %T)2) = 1,  KD(dim−tex) = [Ttot].
3  Results
3.1  Solubility of Purified Recombinant hOAT
hOAT frozen at −20 °C at a concentration higher than 
200  µM in phosphate buffer, forms visible aggregates 
after thawing. On the other hand, apo-hOAT dissolved in 
phosphate buffer is prone to aggregation. In particular, at 
physiological ionic strength it gives rise to visible aggre-
gates. Thus, we checked the solubility of apo- and holo-
hOAT in different buffers and at different ionic strength 
conditions by measuring their propensity to aggregation 
Log(MW) = −0.113Ve + 8.22
(2)Log(2)∕(Vd − Vt) = Log(MW∕D)∕(Vd − Ve),
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as well as the loss of catalytic activity after storage at 
−20 °C. We found that 50 mM Hepes containing 500 mM 
NaCl, pH 7.4, was the buffer that maintained the solubil-
ity of both forms of hOAT. For this reason, the analyses 
comparing the spectroscopic properties and the apparent 
 Tm values of apo and holo were carried out under these 
experimental conditions.
3.2  Spectral and Kinetic Properties of hOAT
Recombinant purified hOAT bind ~2 moles of PLP/mol 
of dimer. The deconvolution of the far-UV CD spectrum 
of the enzyme at 0.3 μM concentration gives a secondary 
structure composition of 37% α-helix, 18% β-sheet and 
45% random coil, values identical to those calculated from 
the solved crystal structure [19]. While apo-hOAT does not 
show any absorbance or dichroic band in the visible region, 
holo-hOAT exhibits two bands at 420 and 340  nm cor-
responding to a positive CD band at 422 nm and a minor 
shoulder around 340  nm, respectively (Fig.  1a, b). The 
 A420/A340 ratio is equal to ~3 in the pH range 6.0–9.0. As 
shown in the inset of Fig. 1a, upon excitation at 420 or at 
340  nm, the fluorescence emission spectra of holo-hOAT 
exhibit a maximum around 505–510 nm, thus allowing us 
to attribute the 420 and 340 nm absorbance and CD bands 
to the ketoenaminic and enoliminic tautomeric forms of 
the PLP-Lys292 [19] internal aldimine, respectively. In the 
near-UV region the apo- and holo-forms of hOAT show a 
positive dichroic band at 284  nm of the same magnitude. 
Upon excitation at 280 nm (Fig. 1c), holo and apo-hOAT 
exhibit an emission maximum at 341 and 342 nm, respec-
tively. The emission intensity of apo-hOAT is roughly two-
fold higher than that of holo-hOAT, as a consequence of the 
quenching of the emission fluorescence due to the bound 
PLP in the holoform. The ANS emission spectrum of apo-
hOAT exhibits an intensity tenfold higher and a maximum 
5  nm blue-shifted as compared with that of holo-hOAT 
(inset of Fig. 1c), thus indicating that the apo-form exposes 
more hydrophobic patches with respect to the holo-form. 
Thus, unlike other PLP-dependent enzymes, for which sig-
nificant changes in the tertiary structure associated with the 
apo-to-holo transition were reported [26, 27], the binding 
of PLP to apo-hOAT does not seem to alter the microenvi-
ronment of aromatic amino acids of the enzyme, but only 
induce a surface alteration of the protein, as suggested by 
the ANS emission fluorescence spectra.
3.3  Quaternary Structure Analysis
To investigate the hOAT oligomerization state, holo 
and apo-hOAT were analysed by AUC and SEC. Each 
sedimentation profile shows a unique peak with a sedi-
mentation coefficient value of S20,W of 9.5 S for the 
holoprotein (Fig.  2a) and 9.6 S for the apoprotein 
(Fig. 2b). Such values correspond to a molecular weight 
of 183 kDa, a value nearly identical to that expected for 
a tetrameric species (183.4  kDa). The SEC analysis of 
holo and apo-hOAT was performed upon pre-incubation 
Fig. 1  Spectroscopic features of wild-type hOAT. a Absorbance 
spectra of holo-hOAT; b CD and c fluorescence spectra of holo- 
(normal line) and apo- (dashed line) hOAT. The inset of a shows the 
coenzyme fluorescence upon excitation at 420 nm (normal line) and 
340 nm (dashed line). The inset of c shows the ANS emission fluo-
rescence spectra of holo- (normal line) and apo- (dashed line) hOAT. 
Spectra were registered at 6  μM enzyme concentration in 50  mM 
Hepes, pH 7.4, 0.5 M NaCl
 R. Montioli et al.
1 3
of both species at concentrations ranging from 0.15 
to 75  μM for 20′ (a time long enough to guarantee the 
achievement of an equilibrium condition) at 25 °C. At 
the highest concentration both species eluted as a sin-
gle peak characterized by a retention volume (Ve) of 
26.2 and 26.5  mL for holo and apo-hOAT, respectively. 
On the basis of the calibration curve such values corre-
spond to an apparent molecular weight of 182  kDa for 
holo-hOAT and 172 kDa for apo-hOAT. Thus, in agree-
ment with AUC results, both species exhibit a molecular 
weight compatible with a tetrameric structure. Moreo-
ver, the Ve of both holo and apo-hOAT increases at 
decreasing enzyme concentrations down to a value cor-
responding to a dimeric species (28.8  mL) (Fig.  3a, b). 
This behavior indicates the presence of both dimeric and 
tetrameric hOAT in rapid equilibrium. Following the 
method of Manning et al. [25], the tetramer–dimer equi-
librium dissociation constants  (KD(tet−dim)) of holo-hOAT 
and apo-hOAT were found to be 0.070 ± 0.005 and 
0.32 ± 0.04  μM (expressed as tetrameric unit), respec-
tively. Accordingly, in DLS experiments, performed at 
0.5  μM enzyme concentration, the hydrodynamic diam-
eter of holo-hOAT resulted ~12  nm, while that of apo-
hOAT was ~9.9 nm (data not shown). On the basis of the 
 KD(tet−dim) values, at 0.5 μM enzyme concentration holo-
hOAT is almost completely in tetrameric form while only 
75% of apo-hOAT is expected to be tetrameric.
3.4  Computational Analysis of the Dimer–Dimer 
Interface
We decided to perform an “in silico” inspection of the 
dimer–dimer interface in a modelled tetrameric structure 
Fig. 2  Sedimentation profile of hOAT. Sedimentation profile of holo 
(a) and apo (b) hOAT. The analysis were performed at 25,000 rpm, at 
20 °C, at a protein concentration of 6 µM in the buffers 50 mM Hepes 
0.5 M NaCl pH 7.4
Fig. 3  SEC analysis of wild-type hOAT. SEC profiles of holo (a) 
and apo (b) hOAT in the concentration range 0.3–15 and 3–75  μM 
respectively. A Sephacryl S300 column equilibrated in 50 mM Hepes, 
pH 7.4, 0.5 M NaCl was used. The inset of a and b show the plot of 
the log(%T/0.04 (100 − %T)2) vs.  log[TTOT] of holo- and apo-hOAT, 
respectively
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with the following aims: (a) define the structural determi-
nants of hOAT tetramerization and (b) understand how PLP 
can stabilize hOAT tetramer. The solved crystal structure 
of hOAT (pdb file 1OAT) comprises one complete dimer 
(chain A and B in Fig. 4a) interacting with one monomer 
(chain C in Fig. 4a) belonging to the neighboring dimeric 
unit. Starting from the existing structures of the hOAT 
dimer and trimer we obtained a tetramer structure that was 
refined by energy minimization (“Materials and Methods” 
section). The model comprises a dimer–dimer interface 
(Fig. 4a) that was analyzed in order to map the inter-chain 
contacts. As expected, all contacts between the hOAT 
dimers are located quite distant from the PLP interaction 
network. The main cluster of inter-dimer contacts is sup-
ported by α-helix 8 of the chains B and C. In particular, 
Glu216 is in contact with the ε-amino group of Lys165* 
while Arg217 is in optimal position to form a H-bond 
with the backbone carbonyl groups of Ser186* or Ser188* 
(*denoting a residue belonging to the neighboring dimer). 
Moreover, the long apolar portion of the Arg217 side chain 
possibly contributes to dimer–dimer hydrophobic interac-
tions, since it lies into a hydrophobic cleft composed by 
Phe200*, Tyr194* and Tyr166* (Fig. 4b). On the basis of 
the above observations on dimer–dimer interface of hOAT, 
we attempted to destabilize the tetrameric assembly. We 
focused our attention on Arg217, whose substitution to Ala 
is expected not only to abolish two polar contacts, but also 
to reduce the hydrophobic contact surface between dimers. 
Moreover, the amino acid conservation analysis generated 
by the Consurf server reveals that Arg217 is conserved in 
mammals (data not shown). On the basis of these bioinfor-
matic analyses, the R217A variant was constructed by site 
directed mutagenesis, expressed and purified.
Fig. 4  Dimer–dimer interface of the hOAT tetramer. a Ribbons 
representation of the hOAT tetramer. The chains of the two dimers 
are indicated and differently colored. Green sticks represent the PLP 
molecules. b Detail of inter-dimer interactions. Residues involved are 
indicated and represented as sticks. The side chains of Tyr166 (a), 
Tyr194 (b) and Phe200 (c) surrounding the Arg217 side chain are 
also represented. Image was rendered using the MOE software (CCG 
group). (Color figure online) Fig. 5  Molecular dimensions of the R217A variant. a SEC profile of 
wild-type hOAT (dashed line) and of the R217A (normal line) vari-
ant at 75 μM concentration on a Sephacryl S300 column. DLS analy-
sis of the size distribution of 6 μM b hOAT wild-type and c R217A. 
Both analyses were performed in 50 mM Hepes, pH 7.4, 0.5 M NaCl, 
at 25 °C
 R. Montioli et al.
1 3
3.5  Characterization of the R217A Variant
The effect of the R217A mutation on the quaternary struc-
ture of hOAT was investigated by SEC analysis and DLS 
measurements. From 1 to 75  μM concentration, R217A 
elutes from SEC as a single symmetric peak with a Ve 
(29  mL) corresponding to a molecular weight of 88  kDa 
attributable to a dimeric species (Fig.  5a). DLS analyses 
indicate that R217A exhibits a mean molecular diameter 
of ~8 nm corresponding to a MW of 80–90 KDa, compat-
ible with a dimeric assembly (Fig. 5b), and no changes of 
the molecular dimensions were observed in the presence of 
l-Orn and α-KG at saturating concentrations. Altogether, 
these results prove that the R217A variant is dimeric up to 
75  μM concentration and maintains the dimeric structure 
upon substrate binding. Thus, it represents a good model to 
study the properties of dimeric hOAT. The absorbance, CD 
and fluorescence spectra of holo- and apo-R217A appear 
substantially identical to those of wild-type hOAT (Online 
Resource Fig.  1). Thus, the R217A substitution does not 
change the secondary and tertiary structure as well as the 
internal aldimine microenvironment of hOAT. The  KD(PLP) 
of R217A results to be 0.28 ± 0.3 μM, a value very simi-
lar to that of the wild-type. However, on the basis of the 
 KD(tet−dim) values, the  KD(PLP) of apo-hOAT wild type has 
been measured for a dimeric apoform which partly under-
went tetramerization upon PLP binding. Unfortunately, we 
could not measure the  KD(PLP) value for the tetrameric apo-
hOAT because of the high enzyme concentration required, 
which would prevent the establishment of equilibrium con-
dition. Thus, we cannot compare the PLP binding affinities 
for dimeric and tetrameric apo-hOAT.
3.6  Functional Properties of Wild-Type hOAT 
and of the R217A Variant
By determining the steady-state kinetic parameters of 
hOAT for the pair l-Orn/α-KG, we found that the Michae-
lis constant  (KM) for l-Orn increases as the buffer ionic 
strength increases reaching a value of 38 mM if measured 
in Hepes 50  mM pH 7.4, 0.5  M NaCl. In order to better 
mimic the physiological ionic strength and pH conditions 
reported for the mitochondrial matrix [28] we measured the 
kinetic parameters in 50 mM Hepes, pH 8.0, 150 mM NaCl. 
At first both wild-type hOAT and R217A were assayed at 
60  nM enzyme concentration at 25 °C. We verified that, 
under these conditions both species are present in solution 
mostly as dimers. For wild-type OAT we calculated  KM 
values of 6.5 ± 0.4 and 3.9 ± 0.5 mM for l-Orn and α-KG, 
respectively, and a k cat of ~35 s−1 (Table 2). These values 
are comparable with those reported for hOAT purified from 
liver [15], and other mammalian aminotransferases [27, 
29] as well as for OATs from plant [8, 9]. The steady state 
kinetic parameters of the R217A variant resulted very simi-
lar to those of wild type hOAT (Table 2), indicating that the 
mutation does not affect the catalytic activity of the enzyme 
and confirming that R217A variant represents a good 
model of the hOAT dimer. To investigate if the tetrameric 
structure could affect the kinetic parameters we performed 
the assays at 1  μM enzyme, a concentration at which the 
wild-type enzyme is mainly tetrameric whereas the R217A 
is dimeric. In order to slow down the rate of catalysis and 
to collect reliable data the assays were performed at 15 °C. 
Results shown in Table 3 indicate that tetrameric wild-type 
OAT and dimeric R217A share the same kinetic parameters 
and reveal that in hOAT the minimal functional unit is the 
dimer and not the tetramer. We could not determine the 
Table 2  Kinetic parameters measured at 25 °C and 60 nM enzyme concentration
Enzymatic species Substrate Co-substrate KM(l−Orn) (mM) KM(α−KG) (mM) kcat  (s−1) kcat/KM  (M−1 s−1)
Wild-type l-Orn α-KG 6.5 ± 0.4 3.9 ± 0.5 34.9 ± 0.6 5.4 ± 0.3
α-KG l-Orn 35.7 ± 0.7 9.1 ± 1.2
R217A l-Orn α-KG 5.1 ± 0.3 2.4 ± 0.1 38.4 ± 0.7 7.5 ± 0.5
α-KG l-Orn 38.1 ± 0.3 15.9 ± 0.8
Table 3  Kinetic parameters measured at 15 °C and 1 μM enzyme concentration
Enzymatic species Substrate Co-substrate KM(l−Orn) (mM) KM(α−KG) (mM) kcat  (s−1) kcat/KM  (M−1 s−1)
Wild-type l-Orn α-KG 7.0 ± 0.5 4.0 ± 0.3 22.6 ± 0.5 3.2 ± 0.2
α-KG l-Orn 20.0 ± 0.3 5.0 ± 0.4
R217A l-Orn α-KG 6.9 ± 0.4 4.4 ± 0.3 20.7 ± 0.4 2.2 ± 0.1
α-KG l-Orn 20.7 ± 0.3 4.7 ± 0.3
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steady state kinetic parameters for the pair GSA:l-gluta-
mate because GSA spontaneously cyclizes to P5C making 
the first half-reaction virtually irreversible.
3.7  Thermal Stability and Aggregation Propensity 
of hOAT
To investigate if PLP could affect the thermal stability of 
the enzyme we determined the melting temperature  (Tm) 
of holo and apo-hOAT in the tetrameric form following the 
decrease of the dichroic signal at 222 and 422 nm, which 
indicate of the loss of the enzyme secondary structure 
and of the bound PLP, respectively (Table 4). Holo-hOAT 
denatured and released PLP in a single-step concerted pro-
cess with apparent melting temperatures of 67.0 ± 0.1 and 
66.8 ± 0.1 °C, respectively. In contrast, apo-hOAT showed 
an apparent  Tm value of 46.1 ± 0.1 °C, a value ~21 °C lower 
than that of the holo-form. As a model of dimeric OAT, we 
determined the apparent  Tm values of both the apo- and 
holo-R217A variant, which resulted similar to the corre-
sponding ones of the wild-type enzyme (Table  4). These 
data indicate that tetrameric and dimeric holo-hOAT share 
a similar resistance to thermal stress which is much higher 
than that of apo-hOAT both in dimeric and tetrameric form. 
Thus, the apo-to-holo transition is associated with a sig-
nificant increase of the protein thermal stability. Since the 
 Tm value of apo-hOAT results quite near to the physiologi-
cal temperature, we examined the susceptibility to unfold-
ing and aggregation under physiological conditions of 
wild-type OAT and of the R217A variant in both apo- and 
holo-form. To this purpose we monitored the CD signal at 
222 nm and the absorbance at 600 nm during the incuba-
tion of 6 μM enzyme in PBS buffer pH 8.0 at 37 °C. While 
no changes could be detected for both holo-forms up to 2 h 
incubation, both apo-forms showed significant changes of 
the 222 nm CD signal and of turbidity reflecting the loss 
of the secondary structure and an ongoing aggregation pro-
cess, respectively (Fig. 6). The half time  (t1/2) of the pro-
cess was determined by fitting the signal changes to a logis-
tic curve. For apo-hOAT wild-type,  t1/2 of 17.9 ± 0.1 and 
19.6 ± 0.2  min were calculated for the unfolding and the 
aggregation processes, respectively. The two values are in 
good agreement, revealing that under physiological condi-
tions apo-hOAT wild-type undergoes a rapid unfolding pro-
cess accompanied by aggregation. A qualitatively similar 
behavior was observed for apo-R217A (Fig.  6). However, 
the  t1/2 for the unfolding and aggregation processes resulted 
to be 12.7 ± 0.2 and 14.7 ± 0.1  min, respectively. Con-
sidering that at 6  μM enzyme concentration apo-hOAT 
wild-type is mainly tetrameric while the mutant form is 
completely dimeric, we could conclude that the tetrameric 
state only slightly enhances the stability of apo-hOAT by 
increasing the halftime of unfolding of ~1.3–1.4 fold.
4  Discussion
The comparison between the biochemical properties of the 
apo- and the holo-forms of hOAT was performed under 
experimental conditions (50  mM Hepes, 500  mM NaCl, 
pH 7.4) in which both forms are soluble. The results reveal 
that apo and holo-hOAT exhibit similar tertiary struc-
ture, as shown by their near-UV CD spectra. Changes of 
the dichroic bands in the near-UV region during the apo 
to holo transition in Fold Type I aminotransferases were 
previously associated with changes in the position/orienta-
tion of aromatic residues at or in proximity of the active 
site [33]. In this family, PLP coordination typically involves 
a planar π base stacking interaction between the PLP pyri-
dine ring and a tryptophan indolic ring, along with an 
Table 4  Melting temperatures of wild-type OAT and R217A variant
Enzymatic species Tm holo (222 nm) (°C) Tm holo (422 nm) (°C) Tm apo (222 nm) (°C)
Wild-type 67.0 ± 0.1 68.6 ± 0.1 45.8 ± 0.1
R217A 68.7 ± 0.1 67.4 ± 0.1 44.3 ± 0.1
Fig. 6  Unfolding and aggregation curves of apo-hOAT wild-type 
and apo-R217A variant under physiological conditions. Trends of the 
CD signal at 222 nm and of the absorbance at 600 nm (inset) during 
the incubation of 6 μM apo-hOAT wild-type (open circle) and apo-
R217A (open square) at 37 °C in PBS pH 8.0. Trends were fitted to a 
logistic curve by Origin7 software (OriginLab)
 R. Montioli et al.
1 3
H-bond interaction between a tyrosine residue belonging to 
the neighboring subunit and the phosphate group of PLP. 
The inspection of the hOAT active site (Online Resource 
Fig.  2) shows that PLP forms a π–π hydrophobic interac-
tion with the phenyl ring of Phe177, which is oriented per-
pendicularly with respect to the pyridine ring, and that the 
phosphate group forms two hydrogen bonds with the pep-
tidic N of Val143 and with the side chain of Thr322* of 
the neighboring subunit. The finding that the typical inter-
actions between PLP and aromatic residues are not present 
in the hOAT coenzyme binding pocket could explain the 
minimal impact of PLP binding on the dichroic features in 
the near-UV region of the protein. Nonetheless, the apo-
form of hOAT exhibits an exposure of hydrophobic sur-
faces to the solvent more pronounced than the holo-form, 
thus suggesting that PLP binding could affect protein con-
formation. This view is supported by the different apparent 
 Tm value of holo-(67 °C) and apo-hOAT (46 °C). Moreover, 
we demonstrated that both holo and apo exist in solution 
as a tetramer. Although these data confirm previous anal-
yses on mammalian OATs purified from different sources 
[13–16], they are in contrast with crystallographic analyses 
indicating the hexameric assembly of the enzyme [18–21]. 
It is possible that the crystallization conditions, known to 
increase the solute concentration over that expected for an 
ideal solution, could promote the hexamerization. Anyway, 
it is of interest to note that apo-hOAT exhibits a  KD(tet−dim) 
value fivefold higher that of holo-hOAT, thus indicating 
that PLP binding plays a role in shifting the equilibrium 
toward the tetrameric species. The ability of PLP to pro-
mote the dimerization of enzymes belonging to the fold 
type I class is well known [30–32]. This is not surprising 
considering that in this class of enzymes the dimer is the 
functional unit as each active site is made of amino acid 
residues provided by both monomers in the dimer. The 
modeled tetrameric structure of hOAT allowed us to estab-
lish that the active site is located far from the tetramer inter-
face. Thus, at present, it is not easy to understand how PLP 
binding can impact the tetrameric structure of the enzyme. 
In this regard, a conformational change has been associ-
ated to the PLP-induced tetramerization of mitochondrial 
human serine hydroxymethyltransferase [33]. The authors 
have suggested that PLP binding to the apoform shifts the 
equilibrium from an “open” to a “close” conformation of 
the dimers promoting the tetramerization. Disappointingly, 
the absence of the apo-hOAT crystal structure makes dif-
ficult to identify structural alterations of hOAT induced by 
PLP-binding. We can only envisage that remote effects of 
PLP binding on the position of Ser186 and Ser188 could be 
transmitted throughout the segment 178–188 starting from 
Phe177 which forms a π–π interaction with the PLP pyri-
dine ring (Online Resource Fig. 3). Additionally, the visual 
inspection of the tetrameric structure allowed us to identify 
Arg217 as a hot-spot at the dimer–dimer interface. There-
fore, an artificial R217A mutant was constructed, cloned, 
purified and characterized. The unexpected finding that the 
mutant form displays a dimeric structure endowed with 
spectroscopic and catalytic features as well as apparent  Tm 
values similar to the corresponding ones of the tetrameric 
form of hOAT demonstrate that the functional unit of the 
enzyme is a dimer and not a tetramer. On this basis, we 
decided to compare the apo- and holo-form of the tetramer 
with those of the dimer under physiological conditions. 
The results reveal that, unlike the holo-tetramer and dimer, 
both apo-tetramer and apo-dimer undergo a rapid unfolding 
process accompanied by aggregation, even if these events 
appear slightly more pronounced for the apo-tetramer than 
for the apo-dimer. Thus, it can be concluded that the holo- 
and apo-hOAT have different conformations under physi-
ological conditions. A reduced stability of the apo-form 
with respect to the holo-form was reported for other PLP-
dependent enzymes both “in vitro” and “in vivo” [34–36]. 
In some cases such behavior has been associated to differ-
ences in the global conformation and/or in the exposure of 
flexible regions [37]. To define the structural features at the 
basis of apo-hOAT instability the resolution of its crystal 
structure would be desirable. It can only be inferred from 
our results that the main determinant of the hOAT thermal 
stability under physiological conditions seems to be the 
binding of the coenzyme rather than the oligomeric state. 
It is reasonable that PLP concentration could greatly affect 
the fate of the enzyme, by increasing its thermal stability 
at physiological temperature and promoting the availability 
of folded OAT. Following this view, the coenzyme could 
represent not only a prosthetic group for hOAT, but also a 
key structural element affecting the OAT turnover. Further 
experiments will be necessary to define if and how the pres-
ence of PLP could influence the stability and the tetrameri-
zation of hOAT “in vitro” and/or in a cellular environment.
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